Scientific Sessions (updated February 19, 2016)
Tuesday (Pre-Congress) | Congress Workshops | Thursday, March 3 | Friday, March 4 | Saturday, March 5 |

ZIKA is on the AGENDA at the 17TH ICID

Dengue, Chikungunya and Zika Virus Go Global, a Symposium organized in collaboration with the Brazilian Society of Infectious Diseases

Zika, MERS, Ebola, SARS and H1N1: Local and Global Responses to Viral Threats, Paul Tambyah, Plenary Lecture

Zika Virus Neurological Associations, Tom Solomon, in the Symposium: Infectious Encephalitis: Advances and Unknown

Congress Workshops


Participation is limited to ICID Registrants. Register Online

Antibiotic Stewardship in the Resource Limited Setting
(in collaboration with the British Society for Antimicrobial Chemotherapy)
Wednesday, March 2, 2016, 13:00 - 17:00hrs
NO FEE - Limited capacity details»

 

Innovative Strategies in Hand Hygiene Promotion Around the World
Wednesday, March 2, 2016, 14:00 - 16:30hrs
NO FEE - Limited capacitydetails»

 

EpiCore Workshop
Saturday, March 5, 2016, 12.30–14.15hrs
NO FEE - Limited capacitydetails»

 

Tuesday, March 1, 2016 – Public Discussion

 

Rise of the Deadly Superbugs- How can we respond?

(Jointly organised by Wellcome Trust/DBT India Alliance, Manthan-India, Public Health Foundation of India, Centre for DNA Fingerprinting and Diagnostics and the 17th International Congress on Infectious Diseases (ICID)

 

This discussion is part of the "Voices for Health" series of public engagement activities and discussions on various health themes this year in different Indian cities, an initiative by the The Wellcome Trust/DBT India Alliance and the Public Health Foundation of India (PHFI).

 

1 March, 2016, 17:30 - 20:00

Saptaparni, Road no. 8 Banjara Hillsdetails»

 

Thursday, March 3, 2016

 

MEET-THE-EXPERT
Why isn’t Mathematical Modeling Being Utilized to Inform Infectious Disease Public Health Policy?
Thursday, March 3, 2016, 07:45 - 08:45hrs, Room: MR G.01-03

M. Roberts (USA)

Clinical Case Discussions for Trainees
Thursday, March 3, 2016, 07:45 - 08:45hrs, Room: Hall 2

V. Gant (United Kingdom)


The Value of Adult Vaccination
(sponsored by MSD)

Thursday, March 3, 2016, 07:45 - 08:45hrs, Room: MR G.05-06

07:45 - 07:50 - Opening Remarks - D. Fedson (France)

07:50 - 08:20 - Herpes Zoster Management - J. Litt (Australia)

08:20 - 08:45 - Pneumococcal Disease in Adults - D. Fedson (France)

 

PLENARY

Streptococcal Lymphatic Metastasis: Bacterial Close Encounters of the Fourth Kind
Thursday, March 3, 2016, 09:00 - 09:45hrs, Room: Hall 4
Chair: K. Klugman (USA)

S. Sriskandan (United Kingdom)

 

PARALLEL SYMPOSIA

Prevention of Childhood Pneumonia Through Vaccination
(in collaboration with the Bill & Melinda Gates Foundation)
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: Hall 1

Co-chairs: K. Klugman (USA), NK Ganguly (India)

  • Global Burden of Pneumonia
    K. Thomas (India)
  • Pneumonia in India
    S. Awasthi (India)
  • Prevention of Pneumonia
    R. Dagan (Israel)
  • The Path to Pneumonia Prevention in India - Call to Action
    R. Kumar (India)

Integrated Symposium

Potential Role of Dengue Vaccination in Integrated Disease Prevention and Control
(developed in collaboration with and supported by an educational grant from Sanofi Pasteur)
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: Hall 2
Co-chairs: A. Biswas (India), N. Malavige (Sri Lanka)

  • The Burden of Dengue: Insights From Large Scale
    clinical studies
    O. Brady (United Kingdom)
  • Recent Update on Dengue Vaccine Development
    P. Pitisuttithum (Thailand)
  • Dengue Vaccination Impact: Perspective From Modeling
    T. Hladish (United Kingdom)
  • Roadmap for Dengue Vaccination Introduction in Mexico
    M. Betancourt (Mexico)

Diagnosis and Treatment of Carbapenem-resistant Enterobacteriaceae
(in collaboration with the Japanese Association for Infectious Diseases)
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: Hall 5
Co-chairs: D. Pittet (Switzerland), T. Matsumoto (Japan)

  • Non-molecular Detection of Carbapenemases in Enterobacteriaceae Clinical Isolates
    L. Martinez-Martinez (Spain)
  • Molecular Diagnosis of Carbapenem-resistant Enterobacteriaceae
    Y. Ishii (Japan)
  • Controlling Carbapenem-resistant Enterobacteriaceae in your Hospital
    L. Munoz-Price (USA)
  • Appropriate Therapy for Carbapenem-resistant Enterobacteriaceae
    O.C. Abraham (India)
    17thICID_Abraham.pdf (654 kB)

Integrated Symposium

Antifungal Prophylaxis Or Treatment - Why, When & What?
(sponsored by MSD)
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: Hall 6
Co-chairs: A. Pagliuca (United Kingdom), A. Srivastava (India)

  • Making Clinical Sense of Candida & Aspergillus Susceptibilties
    N. Wiederhold (USA)
  • Why Prophylaxis for IFI?
    A. Pagliuca (United Kingdom)
  • Risk Stratification for Treatment Or Prophylaxis of Invasive Fungal
    Infections
    M. Slavin (Australia)
  • New Options for Prevention & Treatment of IFI
    R. Duarte (Spain)
HIV - Management of Opportunistic Infections in Low-and-Middle-Income Countries
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: MR G.01-03
Co-chairs: A. Kamarulzaman (Malaysia), N. Kumarasamy (India)
  • HIV/TB Co-infection
    S. Swaminathan (India)
  • Cryptococcal Meningitis and Beyond - Management of Select Opportunistic Infections in Sub-Saharan Africa
    G. Meintjes (South Africa)
  • Challenges in the Management of Opportunistic Infections: Focus on South East Asia
    A. Kamarulzaman (Malaysia)
  • Challenges in the Management of Opportunistic infections: Focus on South America
    J. Torres (Venezuela)
    17thICID_Torres.pdf (1.3 MB)
One Health and Emerging Infectious Diseases
Thursday, March 3, 2016, 10:15 - 12:15hrs, Room: MR G.05-06
Co-chairs: L. Madoff (USA), A. Benkirane (Morocco)
  • Mers-CoV: from Camels to Humans
    Z. Memish (Saudi Arabia)
  • Climate Change and Other Drivers of Infectious Diseases - Focus on Asia and the Pacific
    D. Harley (Australia)
    17thICID_Harley.pdf (1.6 MB)
  • Viral Hemorrhagic Fevers: Ebola and Beyond
    L. Blumberg (South Africa)
    17thICID_Blumberg.pdf (3.6 MB)

  • Rabies: One Health in Action
    P. Cowen (USA)
PLENARY
Challenges and Opportunities in the Management of Chronic Hepatitis B Infection
Thursday, March 3, 2016, 14:30 - 15:15hrs, Room: Hall 4
Chair: A. Kamarulzaman (Malaysia)

C.L. Lai (China)
17thICID_Lai.pdf (1.5 MB)

 

PARALLEL SYMPOSIA

Antibiotic Resistance: National Actions Contribute to a Global Solution
(in collaboration with the Center for Disease Dynamics, Economics & Policy)
Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: Hall 1
Co-chairs: R. Laxminarayan (India), C. Wattal (India)

  • India Perspective on Antibiotic Resistance
    A. Prakash and NK Ganguly (India)
  • South Africa Perspective on Antibiotic Resistance
    TBD and M. Mendelson (South Africa)
    17thICID_Mendelson2.pdf (2.1 MB)
  • Kenya Perspective on Antibiotic Resistance
    R. Kamau and G. Revathi (Kenya)
    17thICID_Revathi.pdf (2.9 MB)
  • Nepal Perspective on Antibiotic Resistance
    R. Chaudhary and P. Pokharel (Nepal)
    17thICID_Pokharel.pdf (282 KB)
  • Mozambique Perspective on Antibiotic Resistance
    M. Saide and B. Sigauque (Mozambique)
  • Lessons Learned
    H. Gellband (USA)
    17thICID_Gelband.pdf (106 KB)

  • Panel Discussion
    R. Laxminarayan (India)

Ebola and Beyond: Preparing for the Next Pandemic

Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: Hall 2
Co-chairs: L. Madoff (USA), M. Chadha (India)

  • India - National Disaster and Epidemic Preparedness
    V. Menon (India)
  • Influenza Preparedness Including H1N1
    M. Chadha (India)
  • Conducting Clinical Trials in the Outbreak Setting - MSF’s Perspective
    H. de Clerck (Belgium)
Advances and Understanding in the Management of Drug Resistant Tuberculosis
Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: Hall 5
Co-chairs: R. Gokhale (India), R. Wallis (USA)
  • Multidrug Resistant TB in Children: Special Considerations
    F. Qamar (Pakistan)
    17thICID_Qamar.pdf (1.3 MB)
  • Diagnostic Advances in Assessing Drug Resistant TB
    C. Rodrigues (India)
  • Translating Genomics Research into Control of MDR Tuberculosis: Lessons Learned and Future Prospects
    M. Nicol (South Africa)
    17thICID_Nicol.pdf (622 KB)
  • Treatment Options for MDR TB and Host Directed Therapies
    R. Wallis (USA)
    17thICID_Wallis.pdf (374 KB)
Malaria - Hot Topics
Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: Hall 6
Chair: N. White (Thailand)
  • The Threat of Antimalarial Drug Resistance
    E. Ashley (UK)
  • Treatment of Drug Resistant Malaria
    A. Pyae Phyo (Thailand)
  • Malaria Prevention Strategies
    L. von Seidlein (Thailand)
  • Management of Relapsing Plasmodium vivax Malaria
    C. Chu (Thailand)
New Insights on Rickettsial Infections
Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: MR G.01-03
Co-chairs: R. Premaratna (Sri Lanka), D. Mathai (India)
  • Epidemiology and Ecology of Rickettsial Infections
    R. Premaratna (Sri Lanka)
    17thICID_Premaratna.pdf (8.3 MB)
  • Challenges and Opportunities in Diagnosis and Treatment
    G. Varghese (India)
  • Current Understanding in Immunopathogenesis and Vaccine Development and the Way Ahead
    D. Walker (USA)
    17thICID_Walker.pdf (7 MB)

Oral Abstract Presentations (1)
Thursday, March 3, 2016, 15:45 - 17:45hrs, Room: MR G.05-06

Emerging Infectious Diseases and One Health
Co-chairs: M. Pollack (USA), S. Handysides (United Kingdom)

  • Expression of glycoprotein gene of Rabies virus and evaluation of recombinant protein for seromonitoring of vaccinal antibodies in dogs
    R. Sharada (INDIA)
  • The EpiCore Project: Using innovative surveillance methods to verify outbreaks of emerging infectious diseases
    Z. Haddad (UNITED STATES OF AMERICA)
  • Effect of non-steroidal anti-inflammatory drugs (NSAIDS) on bleeding and liver in dengue infection
    A. Wijewickrama (SRI LANKA)
  • Clinical features and virology of hand foot mouth disease in Southern Vietnam, July 2013 - March 2015
    V. M. T. Hoang (VIET NAM)
  • Functional Dipeptidyl Peptidase 4 (DPP4) in mink supports entry and replication of Middle Eastern respiratory syndrome coronavirus: American Mink (Neovision vision), a novel in vivo model of MERS-CoV infection
    S. K. Naveen (UNITED STATES OF AMERICA)
  • Multiple introductions of MERS-CoV in a 2014 hospital outbreak in Riyadh, Saudi Arabia
    S. Fagbo (SAUDI ARABIA)
  • Moving Leptospira to the focus of One Health epidemiology: Lessons from large scale genome analysis of pathogenic species
    N. Ahmed (INDIA)
  • Integrated human and animal vaccination delivery to Nomadic Fulani communities in Northern Nigeria 2015
    I. M. Bomoi (NIGERIA)
  • A synthetic consensus anti-Spike protein DNA vaccine induces protective immunity against Middle East Respiratory Syndrome Coronavirus in non-human primates
    K. Muthumani (UNITED STATES OF AMERICA)
  • Climate change and disease dynamics - A big data perspective
    G. Sekaran (INDIA)

return to top

Friday, March 4, 2016

MEET-THE-EDITORS
How to Publish Your Work - Insights From the Editors
(in collaboration with Elsevier)
Friday, March 4, 2016, 07:45 - 08:45hrs, Room: MR G.01-03

E. Petersen (Denmark) (editor-in-chief of the International Journal of Infectious Diseases)
J. McConnell (United Kingdom) (editor of The Lancet Infectious Diseases)

 

MEET-THE-EXPERT
Strengthening Disease Surveillance, Emergency Preparedness and Risk Communication for Health Security in India
(developed by the International Society for Disease Surveillance (ISDS))
Friday, March 4, 2016, 07:45 - 08:45hrs, Room: MR G.05-06

V. Singh (India)
P. Murthy (India)

 

PLENARY
Malaria: Past, Present and Future
"Ronald Ross Memorial Plenary Lecture"
Friday, March 4, 2016, 09:00 - 09:45hrs, Room: Hall 4
Chair. R. Laxminarayan (India)

N. White (Thailand)

 

PARALLEL SYMPOSIA

Infectious Encephalitis: Advances and Unknown
(in collaboration with the Lancet Infectious Diseases)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: Hall 1
Co-chairs: J. McConnell (United Kingdom), L. Kramer (USA)

  • Flavivirus Encephalitis and Other Neurological Syndromes (Japanese Encephalitis, WNV, Tick Borne Encephalitis Virus, Dengue and Zika Virus)
    T. Solomon (United Kingdom)
  • Enterovirus Encephalitis Including Enterovirus 71 and D68
    T. Wong (Malaysia)
  • Acute Encephalitis Syndrome of Unknown Etiology
    A. Desai (India)
  • Rabies Encephalitis
    A. Jackson (Canada)
The Future of Infectious Diseases Diagnostics
(in collaboration with the Indian Association of Medical Microbiologists)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: Hall 2
Co-chairs: S. Jayaraman (India), P. Brown (Jamaica)
  • Maldi-TOF
    A. Chakrabarti (India)
  • Point of Care Testing for Global Health
    V. Gant (United Kingdom)
    17thICID_Gant.pdf (1.1 MB)
  • Whole Genome Sequencing in Diagnostic Microbiology
    T. Peto (United Kingdom)

Childhood Vaccinations: The Old and the New
(in collaboration with the Indian Academy of Pediatrics)
(Supported in part by an unrestricted educational grant from Bharat Biotech and Pfizer Independent Grants for Learning and Change)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: Hall 5
Co-chairs: V. Yewale (India), A. Shet (India)

  • Polio: The Endgame Strategy
    J. John (India)
  • Haemophilus Influenza type B (Hib) Vaccines: A Looming Success. Lessons Learned from the Hib Initiative
    R. Hajjeh (USA)
  • Pneumococcal Conjugate Vaccines
    S. Saha (Bangladesh)
  • Prevention of Enteric Infections: Spotlight on Asia
    G. Kang (India)

Integrated Symposium

Managing the most problematic Gram Negative Bacterial Infections

(sponsored by MSD)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: Hall 6
Co-chairs: M. Bassetti (Italy), V. Ramsubramanian (India)

  • Antibiotic Use & Global Trends of Gram negative Resistance
    C. Rodrigues (India)
  • Risk Stratification: Identifying the right patient
    M. Bassetti (Italy)
  • Strategic Options for Management of GNB infections
    A. Shorr (USA)
  • Role of Antimicrobial Stewardship & Strategies for appropriate Therapy
    G. Karam (USA)
Melioidosis: A South Asian Disease Emerging Globally
(member proposed symposium)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: MR G.01-03
Co-chairs: E. Correa (Sri Lanka), I. Steinmetz (Germany)
  • Melioidosis Endemicity in India
    C. Mukhopadhyay (India)
  • Predicted Distribution of B. pseudomallei and Burden of Melioidosis in South Asia and Worldwide
    D. Limmathurotsakul (Thailand)
  • Why is Melioidosis Difficult to Treat? - Insights into Pathogenesis
    J. Wiersinga (Netherlands)
  • Challenges in Diagnosis and Management of Melioidosis
    D. Dance (United Kingdom)

Oral Abstract Presentations (2)
Friday, March 4, 2016, 10:15 - 12:15hrs, Room: MR G.05-06

HIV and Tuberculosis
Co-chairs: L. Liu (USA), R. Amara (USA)

  • Pattern of HIV-1 drug resistance mutations among patients failing thymidine analogue and non-thymidine analogue based first-line failure in South India
    T. R. Dinesha (INDIA)
  • The impact of HIV infection on the burden and severity of influenza illness in Malawian adults
    A. Ho (MALAWI)
  • Attenuated resting memory B cell compartment in HIV infected children despite Highly Active Antiretroviral Therapy (HAART)
    R. Singh (INDIA)
  • Evaluation of novel rapid bead based method for capturing of Mycobacterium tuberculosis in sputum
    S. Verma (INDIA)
  • Comparative evaluation of in-house Real time IS 6110, nested MPT 64 PCR and Roche AMPLICOR 16s rRNA PCR for diagnosing tuberculous meningitis
    R. Gupta (INDIA)
  • Evolutionary patterns of T cell epitopes in mycobacterium tuberculosis strains isolated in India
    A. Ramaiah (INDIA)
  • Molecular evidence of melioidosis among patients suspected for tuberculosis
    E. Jayakumar (INDIA)
  • Missed pulmonary TB screening opportunities at Primary Healthcare Facilities: An Exit Study, Eastern Cape Province, South Africa 
    P. F. Kweza (SOUTH AFRICA)
  • Performance evaluation of AnyplexII MTB/MDR/XDR for detection of first and second-line drug resistance in Mycobacterium tuberculosis
    L. A. Malinga (SOUTH AFRICA)
  • Impact of Type I IFN dysregulation in M. tuberculosis infection on T cell responses
    A. Ahmed (INDIA)
  • Ps20: A novel correlate of inflammation and infection in TB?
    B. K Sundararaj (INDIA)
PLENARY
Tuberculosis: Challenges and Solutions for the 21st Century
Friday, March 4, 2016, 14:30 - 15:15hrs, Room: Hall 4
Chair: M. Mendelson (South Africa)

S. Swaminathan (India)

 

PARALLEL SYMPOSIA

Intestinal Microbiota in Health and Disease
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: Hall 1
Co-chairs: M. Mitreva (USA, I. Youngster (USA)

  • The healthy Human Antibiotic Resistome: A Multi-body Habitat Analysis
    M. Mitreva (USA)
  • The Role of the Neonatal Microbiome in Health and Disease
    P. Panigrahi (USA)
  • Fecal Microbiota Transplants - The Clinical Perspective
    I. Youngster (USA)
  • Beneficial Modification of Gut Microbiota
    P. Cotter (Ireland)
Pediatric Diarrhea in Low Income Countries: Rotavirus and Beyond
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: Hall 2
Co-chairs: G. Kang (India), M. O'Ryan (Chile)
  • Rotavirus Vaccines - A Promise Kept
    J. Tate (USA)
  • Norovirus Infection and Vaccine Development: Where are we?
    M. O'Ryan (Chile)
  • The Outcomes of Cryptosporidial Infections in Indian Children
    G. Kang (India)
  • Molecular Diagnostics and the Aetiology of Diarrhea in Low-income Countries
    J. Platts-Mills (USA)
Dengue, Chikungunya and Zika Virus Go Global
(in collaboration with the Brazilian Society of Infectious Diseases)
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: Hall 5
Co-chairs: T. Yuill (USA), P. Buchy (Singapore)
  • Dengue, Chikungunya and Zika Virus: Global Emergence
    K. Luz (Brazil)
  • Pathogenesis of Severe Dengue
    N. Malavige (Sri Lanka)
    17thICID_Malavige.pdf (1.3 MB)
  • Management of Severe Dengue
    Y. S Leo (Singapore)
  • Zika Virus, What you Need to Know
    T. Yuill (USA), K. Luz (Brazil), T. Solomon (United Kingdom)
Neglected Infectious Diseases Around the World
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: Hall 6
(in collaboration with the Clinical Infectious Disease Society of India)
Co-chairs: D. Lew (Switzerland), G.K. Varghese (India)
  • Leptospirosis
    D. Diament (Brazil)
    17thICID_Diament.pdf (883 KB)
  • Leprosy
    J. Muliyil (India)
  • Parasitic Infections and Allergies
    P. Cooper (Ecuador/United Kingdom)
  • Infectious Disease Pathology in India: Interactive Cases
    R. Gopalakrishnan (India)
The Silent Epidemic of Hepatitis
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: MR G.01-03
Co-chairs: RK. Ratho (India), F. Amer (Egypt)
  • Hepatitis C Infection in People who Inject Drugs
    T. Azim (Bangladesh)
  • HCV State of the Art: Who, When and How to Treat
    J. Koirala (USA)
  • Egyptian Experience in the Management of HCV Infection
    F. Amer (Egypt)
  • Hepatitis E Vaccine - Where are we Today?
    P. Abraham (India)

Oral Abstract Presentations (3)
Friday, March 4, 2016, 15:45 - 17:45hrs, Room: MR G.05-06

Bacterial Infections and Vaccines
Co-chairs: E. Petersen (Oman), N. Pshenichaya (Russia)

  • Safety, immune lot-to-lot consistency and non-inferiority of a fully liquid pentavalent DTwP-HepB-Hib vaccine: Results from Phase III licensure study of Shan5™
    A. Sil (INDIA)
  • Correlates of county-level non-viral sexually transmitted infection hot spots in the US
    B. Chang (UNITED STATES OF AMERICA)
  • Recombinant accessory cholera enterotoxin of Vibrio cholerae activate ANO6 via RhoA-ROCK-PIP2 signaling to induce secretary diarrhea
    I. A. Sheikh (INDIA)
  • A decade of antimicrobial stewardship at the University of Florida - Challenges, strategies and outcomes
    K. cherabuddi (UNITED STATES OF AMERICA)
  • Guillain–Barré syndrome in Bangladesh: The role TLR4 Asp299Gly and Thr399Ile polymorphisms
    Z. Islam (BANGLADESH)
  • Identification of biofilm-stage specific proteins associated with multidrug resistance and quorum sensing pathway in a pandemic strain of Vibrio parahaemolyticus isolated from India
    A. Dharmaprakash (INDIA)
  • Acquired 16s methyl transferase associated high level aminoglycoside resistance in Acinetobacter baumannii recovered from ICU patients from a tertiary referral hospital of northeast India
    S. Upadhyay (INDIA)
  • Helicobacter pylori infection: Correlation to disease severity and Clarithromycin resistance in a Sri Lankan setting
    N. L. Ubhayawardana (SRI LANKA)
  • Recurrent spontaneous abortion: Significance of early non-invasive detection of Chlamydia trachomatis infection
    N. Singh (INDIA)
  • Zinc restores altered intestinal ion-transport,barrier functions and counteract inflammatory mediators induced by Shigella infection in T84 cells
    P. Sarkar (INDIA)
  • Performance of the matrix assisted laser desorption / ionization time of flight mass spectrometry (MALDI-TOF MS) for accurate identification of routine gram negative bacteria - A reference laboratory experience from Mumbai
    S. Athalye Shetye (INDIA)
  • Challenges and opportunities in antibacterial drug discovery
    K. P. Purnapatre (INDIA)

return to top

Saturday, March 5, 2016
MEET-THE-EXPERT
Clinical Cases in Tropical Dermatology
Saturday, March 5, 2016, 07:45 - 08:45hrs, Room: MR G.01-03

A. Sethi (USA)

 

MEET-THE-EXPERT
Clinical Management of Anti-fungal Resistance - Interactive Cases
Saturday, March 5, 2016, 07:45 - 08:45hrs, Room: MR G.05-06

E. Tagliaferri (Italy)
17thICID_Tagliaferri2.pdf (512 KB)


 

PLENARY
Antimicrobial Resistance: From Problem to Policy to Action

Saturday, March 5, 2016, 09:00 - 09:45hrs, Room: Hall 4
Chair: J. Cohen (United Kingdom)

S. Davies (United Kingdom)

 

PARALLEL SYMPOSIA

Infections in the Era of Cancer Treatments, Transplants and New Biologics
(in collaboration with the Clinical Infectious Diseases Society India and the European Society of Clinical Microbiology and Infectious Diseases)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: Hall 1
Co-chairs: S. Narreddy (India), S. Opal (USA)

New and Recently Approved Antibiotics: Challenges and Opportunities
(in collaboration with DRIVE-AB- a project of the Innovative Medicines Initiative)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: Hall 2
Co-chairs: R. Rangarajan (India), U. Theuretzbacher (Austria)
HIV - Hot Topics in Antiretroviral Therapy and its Consequences
(Supported in part by an unrestricted educational grant from Gilead Grants)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: Hall 5
Co-chairs: Q. Nguyen (Vietnam), D. Mathai (India)
  • HIV Prevention
    K. Mayer (USA)
  • The Good, the Bad and the Beautiful: Anti-retroviral Therapy Considerations in Children and Adolescents
    A. Shet (India)
  • Manifestations and Management of IRIS
    G. Meintjes (South Africa)
  • Impact of Antiretroviral Resistance on Future Treatment Options in Resource Limited Settings
    N. Kumarasamy (India)

Update on Visceral Leishmaniasis in South Asia
(in collaboration with the Drugs for Neglected Diseases initiative)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: Hall 6

Co-chairs: S. Sundar (India), S. Rijal (India)

  • Active Case Finding of Kala-azar
    P. Das (India)
  • Update on Treatment of Kala-azar
    S. Sundar (India)
  • Post-kala-azar Dermal Leishmaniasis: Burden, Diagnosis and Treatment Challenges
    V. Ramesh (India)
  • Management of HIV Visceral Leishmaniasis Co-infection
    S. Burza (United Kingdom)

Infectious Diseases in Refugees, Migrants and Internally Displaced Persons
(supported in part with a North Atlantic Treaty Organization grant)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: MR G.01-03
Co-chairs: M. Mustafa (Sudan), V. Krcmery (Slovakia)

  • The Health of Refugees and Displaced Persons in South Sudan
    J. Wamala (Uganda/South Sudan)
  • Managing Health and Infections in Refugees: Turkey's Experience
    H. Leblebicioglu (Turkey)
  • Rapid Diagnostic Point of Care Tests in Resource Limited Settings
    J. Kafkova (Kenya)
  • Infectious Diseases in Refugees and Migrants During the 2015 European Migrant Crisis
    V. Krcmery (Slovakia)

Oral Abstract Presentations (4)
Saturday, March 5, 2016, 10:15 - 12:15hrs, Room: MR G.05-06
Tropical Infectious Diseases

Co-chair: RK. Barigala (India), L. Lutwick (USA)

  • From evidence to impact: Improving treatment for Kala Azar patients in India
    R. Mahajan (INDIA)
  • In silico and experimental studies of Plasmodium serpentine receptor predicts its role as putative purineric receptor  
    S. Gupta (INDIA)
  • Modelling Prevalence and Intensity of Schistosomiasis and Soil Transmitted Helminths Infections and Deworming Requirement in Ogun State, Nigeria.
    A. S. Oluwole (NIGERIA)
  • Assessment of effect of intermittent preventive treatment of malaria in pregnancy on birth weight of babies in Nigeria: Life-saving dynamics
    Y. F. Oke (NIGERIA)
  • Rickettsial disease IFA-IgG titres in auto-immune diseases: What do they imply?
    R. Premaratna (SRI LANKA)
  • Novel tick-borne Rickettsia sp. from wild ticks of Kenya: Implications for emerging vector-borne disease outbreaks
    M. M. Mwamuye (KENYA)
  • Twelve months outcome in kala-azar patients treated with 3 novel regimens, at public health care facilities in Bihar
    V. Goyal (INDIA)
  • Post kala-azar dermal leishmaniasis treated with liposomal amphotericin B (AmBisome)
    R. Mahajan (INDIA)
  • Multilocus sequence typing of seven genetic loci to discriminate strains of L. donovani isolated from Bangladesh
    S. S. Banu (AUSTRALIA)
  • The effect of TNF-α neutralization on parasite load and cytokine production in human visceral leishmaniasis
    N. Singh (INDIA)
  • The baboon (Papio anubis)-Plasmodium knowlesi model of placental malaria
    F. I. Onditi (KENYA)
PLENARY
Zika, MERS, Ebola, SARS and H1N1: Local and Global Responses to Viral Threats
Saturday, March 5, 2016, 14:30 - 15:15hrs, Room: Hall 4
Chair: R. Hajjeh (USA)

P. Tambyah (Singapore)
17thICID_Tambyah.pdf (12.5 MB)

 

PARALLEL SYMPOSIA
Sepsis and Other Infections in Critical Care
(in collaboration with the Clinical Infectious Diseases Society India)
Saturday, March 5, 2016, 15:45 - 17:45hrs, Room: Hall 2
Co-chairs: J. Cohen (United Kingdom), B. Veeraraghavan (India)

Enteric Fever Prevention and Control Strategies
Saturday, March 5, 2016, 15:45 - 17:45hrs, Room: Hall 5
Co-chairs: A. Zaidi (USA), G. Matar (Lebanon)

  • Disease Burden of Typhoid Fever: Updates from the SEAP Project
    D. Garrett (USA)
    17thICID_Garrett.pdf (688 KB)
  • Development Status of Typhoid Conjugate Vaccines Globally
    S. Sahastrabuddhe (Republic of Korea)
  • Strategies on Containing and Treating Drug Resistant Typhoid in Low and Middle Income Countries
    A. Arjyal (Nepal)
  • Typhoid Global Policy Recommendations
    A. Zaidi (USA)

Protecting the Healthcare Worker Around the World
Saturday, March 5, 2016, 15:45 - 17:45hrs, Room: Hall 6
Co-chairs: A. Holmes (United Kingdom), A. Kapil (India)

  • Protecting the Healthcare Worker Around the World
    R. Gallagher (United Kingdom)
  • Technologies for Hospital Disinfection and Textiles for Bioburden Reduction
    G. Bearman (USA)
    17thICID_Bearman.pdf (1.4 MB)
  • The Impact of Education on Reducing Ebola Virus Disease Transmission in Healthcare Facilities
    S. Mehtar (South Africa)
    17thICID_Mehtar.pdf (3.2 MB)
  • Protecting the Healthcare Worker During Outbreaks - Médecins sans Frontieres Perspective
    H. de Clerck (Belgium)
    17thICID_DeClerk.pdf (2.6 MB)

Sexually Transmitted Infections: Global Challenges
Saturday, March 5, 2016, 15:45 - 17:45hrs, Room: MR G.01-03
Co-chairs: S. Mehendale (India), H. Rees (South Africa)

return to top